Lepodisiran, an experimental drug by Eli Lilly, reduces the risk of genetic heart disease by 94%. The drug significantly ...

The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, uncontrolled and “true” treatment-resistant hypertension, according to data ...

About 2,000 people gathered at the SRC arena for the 2025 Syracuse Heart Walk on Sunday, March 30. The Heart Walk is an ...

What causes heart disease? Heart disease is a broad reference to multiple heart conditions. The most common is coronary ...

A show of hands at the ACC town hall demonstrated unity as specialists investigate options for a new certifying board outside the current one or with two parent sponsors.

Despite showing no overall benefit, the in-home paramedic visit appeared to help women avoid readmissions more than men.

Young adults face rising heart health risks; better habits, support, and healthcare access can protect lifelong heart health.

Country star Carly Pearce shared a health update with Fox News Digital after she was diagnosed with a heart condition called ...

Oral semaglutide reduced risk for major adverse CV events by 14% in high-risk adults with type 2 diabetes regardless of SGLT2 ...

However, presenter Eileen Handberg, PhD, ARNP, of the University of Florida in Gainesville, emphasized that WARRIOR was not a ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Babies born with heart defects may be at increased risk for cancer within the first 10 years of life, according to new research that suggests mothers may ...